BR112022003464A2 - Composição farmacêutica - Google Patents

Composição farmacêutica

Info

Publication number
BR112022003464A2
BR112022003464A2 BR112022003464A BR112022003464A BR112022003464A2 BR 112022003464 A2 BR112022003464 A2 BR 112022003464A2 BR 112022003464 A BR112022003464 A BR 112022003464A BR 112022003464 A BR112022003464 A BR 112022003464A BR 112022003464 A2 BR112022003464 A2 BR 112022003464A2
Authority
BR
Brazil
Prior art keywords
sulfate
pharmaceutical composition
chondroitin
nasal
reducing agent
Prior art date
Application number
BR112022003464A
Other languages
English (en)
Inventor
Hideki Watanabe
Kanako Yoshida
Koki FUJIKAWA
Shigeharu Fujieda
Tetsuji Takabayashi
Original Assignee
Maruho Kk
Univ Fukui
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruho Kk, Univ Fukui filed Critical Maruho Kk
Publication of BR112022003464A2 publication Critical patent/BR112022003464A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

composição farmacêutica. a presente invenção se refere a um agente redutor de pólipos nasais contendo um polissacarídeo selecionado de um sulfato de condroitina polissulfatado, sulfato de condroitina, sulfato de dermatano, sulfato de queratano, sulfato de heparano, sulfato de dextrano, polissulfato de pentosano (pps), condroitina, glucomanano, inulina e xilo-oligossacarídeo ou um sal do mesmo como um ingrediente ativo, uma composição farmacêutica, um método para reduzir pólipos nasais ou um método para prevenir/tratar pólipos nasais. de acordo com a presente invenção, é possível prover um agente redutor de pólipos nasais eficaz e seguro.
BR112022003464A 2019-09-20 2020-09-18 Composição farmacêutica BR112022003464A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019170955 2019-09-20
PCT/JP2020/035438 WO2021054440A1 (ja) 2019-09-20 2020-09-18 医薬組成物

Publications (1)

Publication Number Publication Date
BR112022003464A2 true BR112022003464A2 (pt) 2022-05-24

Family

ID=74883058

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022003464A BR112022003464A2 (pt) 2019-09-20 2020-09-18 Composição farmacêutica

Country Status (8)

Country Link
US (1) US20220347093A1 (pt)
EP (1) EP4032535A4 (pt)
JP (1) JP7313019B2 (pt)
CN (1) CN114650828A (pt)
AU (1) AU2020349263B2 (pt)
BR (1) BR112022003464A2 (pt)
CA (1) CA3154360C (pt)
WO (1) WO2021054440A1 (pt)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3497209B2 (ja) 1993-08-24 2004-02-16 生化学工業株式会社 硫酸化糖の脱硫酸化方法
JP3512277B2 (ja) 1995-10-05 2004-03-29 有限会社ジーオーメディカルサービス 鼻茸治療・予防剤
JPH10203988A (ja) 1997-01-27 1998-08-04 Meiji Milk Prod Co Ltd 鼻茸および鼻粘膜の浮腫性病変の治療剤
JPH11335288A (ja) * 1998-05-20 1999-12-07 Maruho Co Ltd アレルギー性疾患の予防または治療薬
WO2000069917A1 (fr) * 1999-05-18 2000-11-23 Maruho Kabushikikaisha Compositions medicinales destinees a inhiber le systeme kallikreine-kinine ou la phospholipase a¿2?
EA200800489A1 (ru) 2005-08-03 2008-12-30 Морриа Байофармасьютикалс Применение липидных конъюгатов при муковисцидозе и их приложения
US20140005115A1 (en) * 2005-11-17 2014-01-02 Yissum Research Development Company Lipid conjugates in the treatment of bronchitis
US8859524B2 (en) * 2005-11-17 2014-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of chronic rhinosinusitis
CA2790682C (en) 2010-03-03 2020-11-24 Neocutis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
US10059771B2 (en) 2013-06-21 2018-08-28 Sanofi Biotechnology Methods for treating nasal polyposis by administering an IL-4R antagonist

Also Published As

Publication number Publication date
CA3154360A1 (en) 2021-03-25
AU2020349263B2 (en) 2023-08-17
EP4032535A4 (en) 2023-10-25
JPWO2021054440A1 (pt) 2021-03-25
US20220347093A1 (en) 2022-11-03
CA3154360C (en) 2024-01-23
WO2021054440A1 (ja) 2021-03-25
EP4032535A1 (en) 2022-07-27
AU2020349263A1 (en) 2022-04-14
CN114650828A (zh) 2022-06-21
JP7313019B2 (ja) 2023-07-24

Similar Documents

Publication Publication Date Title
EP2540284A3 (en) Compositions and methods for stabilized polysaccaride formulations
BR112015011497A2 (pt) composto, formulação farmacêutica, produto de combinação, e, método de tratamento de uma doença
JP2011518838A5 (pt)
MX2019010189A (es) Polisulfato de pentosan, composicion farmaceutica y anticoagulante.
Johal et al. Viscosupplementation in knee osteoarthritis: evidence revisited
EA201792487A1 (ru) Композиции гидроксипропил-бета-циклодекстринов и способы
BR112016024454A2 (pt) solução oftálmica aquosa e método para o tratamento da síndrome do olho seco
MA55365A (fr) Procédés de production de bioconjugués de polysaccharides o-antigènes d' e. coli, compositions de ceux-ci et leurs procédés d'utilisation
BR112021021857A2 (pt) Métodos para formação de complexos de inclusão com derivados de beta-ciclodextrina hidrofílicos e composições dos mesmos
BR112015020000A2 (pt) fibra kraft quimicamente modificada e métodos de fabricação da mesma
BR112015017246A2 (pt) formulação farmacêutica que compreende um corticosteroide insolúvel e um corticosteroide solúvel
NZ603479A (en) Chitosan composition
MX2021012400A (es) Métodos y composiciones para su uso en el tratamiento del cáncer sin efectos psicoactivos.
MX2019009711A (es) Mejoras en o con respecto a compuestos organicos.
BR112022003464A2 (pt) Composição farmacêutica
Ludwig et al. Management of cutaneous type IV hypersensitivity reactions induced by heparin
EP3082869B1 (en) Combination of glycosaminoglycans and cyclodextrins
BR112018004538A2 (pt) processo para produção de pelo menos um de fibra celulósica, arabinoxilano solúvel em água, arabinoxilano ramificado de baixo peso molecular ou arabinoxilano de baixo peso molecular, uso de uma composição, ingrediente, composição, e, fibra
PT3257516T (pt) Composição farmacêutica compreendendo cetraria islandica ach., hialuronato de sódio e uma solução salina para tratamento de doenças do sistema respiratório
IT201600079773A1 (it) Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
BR112014027712A2 (pt) tratamento de hemorragia pós-parto com heparina ou sulfato de heparano quimicamente modificados e um agente uterotônico
Williams Intraarticular hyaluronic acid supplementation in the horse: The role of molecular weight
BR112015024462A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor da xantina oxidase, e, agente terapêutico ou profilático para uma doença
Hallgren et al. Disease-Specific Alterations in Glycosaminoglycans in IPF and COPD
RU2018144958A (ru) Композиции, содержащие полисахаридную матрицу для контролируемого высвобождения активных ингредиентов